BCAS2 Protein (T7 tag,His tag)
-
- Antigène Voir toutes BCAS2 Protéines
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- Type de proteíne
- Recombinant
-
Origine
- Humain
-
Source
- Escherichia coli (E. coli)
- Purification/Conjugué
- Cette BCAS2 protéine est marqué à la T7 tag,His tag.
- Fonction
- Recombinant Human BCAS2/DAM1 Protein (His & T7 Tag)
- Séquence
- Ala2-Phe225
- Attributs du produit
- Recombinant Human Breast Carcinoma-Amplified Sequence 2 is produced by our E.coli expression system and the target gene encoding Ala2-Phe225 is expressed with a T7 tag at the N-terminus, 6His tag at the C-terminus.
- Pureté
- > 90 % as determined by reducing SDS-PAGE.
- niveau d'endotoxine
- < 1.0 EU per μg as determined by the LAL method.
- Top Product
- Discover our top product BCAS2 Protéine
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Please refer to the printed manual for detailed information.
- Buffer
- Lyophilized from a 0.2 μm filtered solution of 20 mM TrisHCl, 200 mM NaCl, 2 mM DTT, pH 8.0.
- Stock
- 4 °C,-20 °C,-80 °C
- Stockage commentaire
- Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
-
- Antigène
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- Autre désignation
- BCAS2/DAM1 (BCAS2 Produits)
- Synonymes
- DAM1 Protein, SPF27 Protein, Snt309 Protein, 6430539P16Rik Protein, AI132645 Protein, C76366 Protein, C80030 Protein, BCAS2 Protein, cb302 Protein, zgc:101730 Protein, BCAS2, pre-mRNA processing factor Protein, breast carcinoma amplified sequence 2 Protein, breast carcinoma amplified sequence 2 L homeolog Protein, BCAS2 Protein, Bcas2 Protein, bcas2 Protein, bcas2.L Protein, CpipJ_CPIJ003889 Protein
- Sujet
-
Background: Breast Carcinoma-Amplified Sequence 2 (BCAS2) is a member of the SPF27 family. BCAS2 is a nuclear protein and widely expressed in many rtissues. BCAS2 is identified as being overexpressed in various breast cancer cell lines. BCAS2 is a component of the spliceosome, taking part in the removal of introns from mRNA precursors. BCAS2 interacts with estrogen receptor alpha and beta, thyroid hormone receptor beta, peroxisome proliferator-activated receptor gamma. BCAS2 functions as an ER co-activator and is capable of enhancing ER-mediated transcription.
Synonym: Pre-mRNA-Splicing Factor SPF27, Breast Carcinoma-Amplified Sequence 2, DNA Amplified in Mammary Carcinoma 1 Protein, Spliceosome-Associated Protein SPF 27, BCAS2, DAM1
- Poids moléculaire
- 28.6 kDa
- UniProt
- O75934
-